Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients. (Q47704709)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

6 November 2019

title

Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

Langerhans cell histiocytosis specific to childhood

6 November 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Schultze A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

6 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

6 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

687-694

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

Histiocytosis X. Clinical aspects and course in 5 patients

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Allogeneic bone marrow transplantation for Langerhans' cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Epidemiologic study of Langerhans cell histiocytosis in children

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Cytogenetic abnormalities in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH).

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

The radiological manifestations of disseminated histiocytosis X in adults (author's transl)

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Radiologic features of eosinophilic granuloma of bone

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

A comparison of radiographic and bone scan findings in histiocytosis X

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Langerhans cell histiocytosis in the adult

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Immunobiology of histiocytosis-X.

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Langerhans cell histiocytosis in children under 2 years of age.

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Evaluating the role of therapy in histiocytosis-X. Clinical studies, staging, and scoring

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Successful treatment of two children with Langerhans' cell histiocytosis with 2'-deoxycoformycin

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Chemotherapy of reticuloendotheliosis:Comparison of methotrexate plus prednisone vs. vincristine plus prednisone

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Interleukin-2 therapy of Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Combination Chemotherapy in Histiocytosis X

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Histiocytosis X--comparison of three treatment regimens

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Histiocytosis X: a review of 114 cases with oral involvement

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

Oral Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016/S1368-8375(03)50080-0

7 January 2021

10.1016/S1368-8375(03)00080-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12907208 AND SRC:MED&resulttype=core&format=json

6 November 2019

1 reference